Group1 | Group2 | P value | |
---|---|---|---|
Control group (76) | treated group (389) | ||
CKD stage number(percent) | 0.99 | ||
3a:60>GFR≥45 | 14(18.4) | 140(36.0) | |
3b:45>GFR≥30 number(percent) | 35(46.1) | 180(46.3) | |
4:30>GFR≥15 number(percent) | 27(35.5) | 69(17.7) | |
(GFRcc/min/1.73m2) | |||
CKD stage (RRT+death)/total(%) | 0.048* | ||
3a: | (3+0)/14(21.4) | 34.66±11.03 | |
3b: | (9+2)/35(31.4) | (11+5)/180(8.9) | |
4: | (5+1)/27(22.2) | (5+1)/69(8.7) | |
GFRcc/min/1.73m2 mean±SD | 35.09±10.56 | (38+7)/140(32.1) | 0.753 |
Age(years) mean±SD | 56.5±17.3 | 62.3±14.2 | 0.008* |
Diabetes mellitus | 23(30.3%) | 130(33.4%) | 0.328 |
Sex(Male/Female) | 43/33=1.3 | 234/155=1.5 | 0.324 |
Anemia(Hb<11gr/dl) | 13/48 | 42/203 | 0.218 |
Systolic HTN(>14CmHg) | 32/60 | 113/312 | 0.010* |
Systolic Blood pressure (CmHg) mean±SD | 14.91±2.85 | 13.82±2.68 | 0.005* |
Diastolic Blood pressure (CmHg) mean±SD | 8.34±1.47 | 7.74±1.30 | 0.001* |
Hemoglobin(gr/dl) mean±SD | 12.58±2.51 | 12.61±2.03 | 0.913 |
Calcium(mg/dl) mean±SD | 9.12±0.70 | 9.22±1.00 | 0.681 |
Phosphorus(mg/dl) mean±SD | 4.30±1.07 | 4.04±0.77 | 0.348 |
Uric acid(mg/dl) mean±SD | 7.45±1.84 | 9.46±12.84 | 0.549 |
Cholesterol(mg/dl) mean±SD | 209.56±57.66 | 196.19±69.14 | 0.251 |
Triglyceride(mg/dl) mean±SD | 266.14±181.11 | 192.40±119.00 | 0.048 |